Intelligence » Amyotrophic Lateral Sclerosis » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

BrainStorm enrolls first patients in advanced ALS stem cell trial

Monday, October 16, 2017 -- TEL AVIV (Reuters) - BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS) at Massachusetts General Hospital and UC Irvine Medical Center in California.

ALS Risk Reduced With Exposure to Exogenous Hormones

Thursday, October 12, 2017 -- Results suggest that sex hormones may play a role in the development of amyotrophic lateral sclerosis.